Cabaletta Bio
IPOCabaletta Bio, Inc.
Public · Philadelphia, PA, United States
- Headquarters
- Philadelphia, PA
- Business Model
- B2B
- Website
- cabalettabio.com
- Last Round
- Series BJan 2019
- Rounds
- 2
- Type
- Public
About
Cabaletta Bio is a clinical-stage biotechnology company developing targeted CAAR T cell therapies to cure autoimmune diseases.
Summary
Cabaletta Bio is a Biotech company based in Philadelphia, PA, United States. Its most recent funding was a Series B round in Jan 2019. Investors include Deerfield Management, Adage Capital and Boxer Capital.
Tech & App Stack
2 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Oct 2019
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...